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ne of several features acquired by chromatin of the
inactive X chromosome (Xi) is enrichment for the
 
core histone H2A variant macroH2A within a
distinct nuclear structure referred to as a macrochromatin
body (MCB). In addition to localizing to the MCB,
macroH2A accumulates at a perinuclear structure centered
at the centrosome. To better understand the association of
macroH2A1 with the centrosome and the formation of an
MCB, we investigated the distribution of macroH2A1
throughout the somatic cell cycle. Unlike Xi-speciﬁc RNA,
 
which associates with the Xi throughout interphase, the
appearance of an MCB is predominantly a feature of S
O
 
phase. Although the MCB dissipates during late S phase
 
and G
 
2
 
 before reforming in late G
 
1
 
, macroH2A1 remains
associated during mitosis with speciﬁc regions of the Xi,
including at the X inactivation center. This association
yields a distinct macroH2A banding pattern that overlaps
with the site of histone H3 lysine-4 methylation centered at
the DXZ4 locus in Xq24. The centrosomal pool of
macroH2A1 accumulates in the presence of an inhibitor of
the 20S proteasome. Therefore, targeting of macroH2A1 to
the centrosome is likely part of a degradation pathway, a
 
mechanism common to a variety of other chromatin proteins.
 
Introduction
 
Male and female eutherian mammals achieve equivalent lev-
els of X-linked gene expression by silencing all but one X
chromosome in cells of the developing embryo (Avner and
Heard, 2001; Willard, 2000). With the exception of im-
printed X inactivation in extraembryonic tissue (Huynh and
Lee, 2001), the choice of which X chromosome to inactivate
in the soma is random and maintained throughout subse-
quent cell divisions. The inactive X chromosome (Xi)*
shares features common to other types of heterochromatin,
including hypoacetylation of histone tails (Jeppesen and
 
Turner, 1993; Belyaev et al., 1996; Boggs et al., 1996;
Gilbert and Sharp, 1999), hypermethylation of CpG islands
(Mohandas et al., 1981; Pfeifer et al., 1990), late replication
in S phase (Gilbert et al., 1962; Morishma et al., 1962), and
a characteristic pattern of histone H3 lysine methylation
(Boggs et al., 2002; Peters et al., 2002). In addition, several
unique features characterize heterochromatin of the Xi.
 
These include the association of a large untranslated RNA, the
Xi-specific transcript (XIST) (Brown et al., 1991; Brockdorff
et al., 1992), and a nonrandom distribution of variants of
 
the core histone H2A (Costanzi and Pehrson, 1998; Chadwick
and Willard, 2001a,b).
 
The macroH2A family of H2A variants was first identified
through association with nucleosomes (Pehrson and Fried,
1992). The amino-terminal third of the protein is almost
identical to histone H2A, with a unique nonhistone carboxy-
terminal tail. Two separate genes encode macroH2A1 and
macroH2A2, both of which are enriched in Xi chromatin
(Costanzi and Pehrson, 1998, 2001; Chadwick and Willard,
2001a). The enrichment of macroH2A at the Xi forms a
characteristic structure in the female nucleus, referred to as a
macrochromatin body (MCB). In cultured differentiating
mouse embryonic stem cells (ES), an MCB appears after
counting and choice of which X chromosome to inactivate
has occurred (Mermoud et al., 1999; Rasmussen et al.,
2000). Although macroH2A has transcriptional repression
activity (Perche et al., 2000), it is not essential for the main-
tenance of X inactivation. The formation of an MCB is de-
pendent upon localization of XIST RNA, as disruption of
XIST results in the loss of the MCB without reactivating the
Xi (Csankovszki et al., 1999; Beletskii et al., 2001). Com-
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bined, the available data indicate that macroH2A may repre-
sent one of several highly redundant mechanisms of gene si-
lencing employed by the Xi (Mohandas et al., 1981; Singer-
Sam et al., 1992; Brown and Willard, 1994; Gartler and
Goldman, 1994; Csankovszki et al., 1999).
Prior to the onset of X inactivation in ES cells, a cytoplasmic
concentration of macroH2A1 is evident, coincident with the
centrosome (Rasmussen et al., 2000). When ES cells are stimu-
lated to differentiate, centrosomal macroH2A disappears. More
recently, a centrosome-associated pool of macroH2A1 has been
observed in somatic cells as well (Mermoud et al., 2001), rais-
ing questions about the relationship between nuclear and cen-
trosomal macroH2A1. In the present study, in order to address
the spatial and temporal relationship of macroH2A1 with the
centrosome and the MCB, we have investigated the distribu-
tion of macroH2A1 during the maintenance phase of X inacti-
vation throughout the somatic cell cycle.
 
Results
 
MacroH2A1 and macroH2A2 associate with 
centrosomes in male and female somatic cells
 
A centrosomal association of macroH2A1 was observed in
human somatic cells (Fig. 1 a), as previously observed in
 
mouse (Mermoud et al., 2001), indicating that the centroso-
mal macroH2A1 pool is not restricted to undifferentiated ES
cells (Mermoud et al., 1999; Rasmussen et al., 2000). In ad-
dition, the association with centrosomes in both XY and XX
somatic cells indicates that the association is independent of
X inactivation. Using independent antisera specific to either
the macroH2A1 or the macroH2A2 protein, we detected
both forms of macroH2A at the centrosome (Fig. 1 b).
Both forms of macroH2A could also be detected in
sucrose gradient fractions enriched for centrosomes (Fig.
2 a). In addition to a signal of anticipated size for
macroH2A1, a second band of smaller size was detected
in centrosome preparations (Fig. 2 a, lane 1). The same
band cofractionates with full-length macroH2A1 in su-
crose gradient fractions of nucleosome preparations (Fig.
2 b). Additional bands of comparable size have been de-
tected with independent anti-macroH2A1 antisera (Cos-
tanzi et al., 2000; Mermoud et al., 2001). Although a
smaller macroH2A2 band is not detected in centrosome
preparations (Fig. 2 a, lane 2), a considerably weaker
Figure 1. Colocalization of macroH2A with centrosomes in 
somatic cells. (a) Colocalization of macroH2A1 (green, FITC) with 
 -tubulin (red, TRITC) in 46,XX (T-3352) and 46,XY (hTERT-BJ1) 
cells. Nuclei are stained with DAPI (blue). The white arrowhead 
indicates the position of the centrosome, determined by  -tubulin 
staining. The merged macroH2A1 and  -tubulin signals indicate 
overlapping signals in yellow. The white arrow indicates the location 
of the MCB (green) in the 46,XX nucleus. (b) Colocalization of 
macroH2A1 and macroH2A2 with  -tubulin in 46,XX (hTERT-RPE1) 
cells by indirect immunofluorescence. Cells grown directly on 
microscope slides were stained with either anti-macroH2A1 or anti-
macroH2A2 (aa 124–180). Metaphase chromosomes are stained 
with DAPI. The white arrowhead indicates the position of the 
centrosome, determined by  -tubulin staining. The merged macroH2A 
and  -tubulin signals indicate overlapping signals in yellow.
Figure 2. Detection of macroH2A1 and macroH2A2 in fractions 
from nucleosome and centrosome preparations. (a) Immunoblot 
analysis of the same fraction of a centrosome preparation from a 
46,XX (hTERT-RPE1) cell line detecting the presence of macroH2A1 
(lane 1) or macroH2A2 (aa 124–372; lane 2). The panel below 
shows the relative level of  -tubulin by immunoblotting in the same 
fraction. (b) Immunoblot of five consecutive sucrose gradient fractions 
(lanes 1–5) of a nucleosome preparation from a 46,XX (hTERT-RPE1) 
cell line, showing the cofractionation of full-length macroH2A1 (top 
arrowhead) and a smaller signal (bottom arrowhead). The relative 
concentration of nucleosomes/histones in each fraction is shown in 
the Coomassie image below. (c) Immunoblot analysis of the same 
nucleosome-containing fraction of a nucleosome preparation from 
a 46,XX (hTERT-RPE1) cell line detecting the presence of 
macroH2A1 (lane 1) or macroH2A2 (aa 124–372; lane 2). The 
panel below shows an image of the Coomassie stain of the same 
fraction indicating the positions of the histones. (d) Immunoblot 
analysis using anti-Myc mAb detecting the presence of macroH2A1-
CT–Myc and macroH2A2-CT–Myc in sucrose gradient fractions of 
nucleosome preparations from macroH2A1-CT–Myc- and 
macroH2A2-CT–Myc-expressing HEK-293 cell lines. The arrow-
heads to the right of each image indicate the presence of the upper 
full-length macroH2A1/2–Myc and a smaller macroH2A1/2–Myc-
derived form. The relative concentration of nucleosomes/histones 
in each fraction is shown in the Coomassie image below. 
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smaller band can be detected in nucleosome fractions
with antisera specific to macroH2A2 (Fig. 2 c, lane 2).
Smaller bands can also be observed in nucleosome prepa-
rations from cell lines expressing epitope-tagged forms of
macroH2A1 and macroH2A2 (Fig. 2 d). Although the
smaller bands observed for the epitope-tagged forms of
macroH2A1 and macroH2A2 do not directly correlate
to the size of the smaller bands detected with the
macroH2A1 and macroH2A2 primary antisera, this may
reflect either a direct effect of the presence of the epitope
tag on processing or the relative stability of the endoge-
nous proteins. Whether the smaller bands represent the
potential breakdown of macroH2A during various purifi-
cation protocols, or the direct result of an intracellular bi-
ological process is unknown. Further, though less likely in
our view because of its reproducibility with three inde-
pendent antisera, the possibility remains that the smaller
bands may be unrelated to macroH2A and simply repre-
sent a shared epitope between macroH2A and another
protein(s) that coexists with macroH2A in both nucleoso-
mal and centrosomal fractions.
 
Both macroH2A1 and macroH2A2 concentrate in 
distinct bands on the human and mouse Xi
 
Previous observations have indicated that macroH2A1 is
uniformly associated with the mouse Xi at metaphase
(Costanzi and Pehrson, 1998; Mermoud et al., 1999). We
have investigated the relationship of macroH2A with the
human and mouse Xi and consistently observed a distinct
banding pattern on the Xi chromosome (Fig. 3). As previ-
ously observed, macroH2A associates with the autosomes
and active X chromosome (Xa) in human metaphase
spreads as well, but at a significantly lower level than that
for the Xi (Fig. 3 c and Fig. 4 a). The same banding pattern
is observed using antisera specific to either macroH2A1 or
macroH2A2, indicating that the bands contain both iso-
forms (Fig. 3 a).
Up to four macroH2A bands were observed on the Xi in
a variety of human 46,XX cell lines (Fig. 3; unpublished
data). To determine the precise location of each band, we
stained metaphase chromosomes with macroH2A in com-
bination with FISH using a number of ordered and pre-
viously mapped X chromosome probes. This approach
placed the macroH2A bands at Xp22, Xp11, Xq13, and
Xq22-24, with the most intense and consistent band at
Xq22-24 (Fig. 3). Notably, the band at Xq13 was indis-
tinguishable from a cosmid probe containing the XIST lo-
cus at the X inactivation center (Fig. 3 b). All four bands
were reproduced in a 46,XX cell line overexpressing ei-
ther an amino- or carboxy-terminal epitope-tagged form of
macroH2A1 (Fig. 4, b and c), confirming the identity of
the bands.
To extend this observation, we investigated the distribu-
tion of macroH2A1 on the mouse Xi at metaphase. As seen
in humans, macroH2A1 formed a characteristic banding
pattern on the mouse Xi (Fig. 3 d). Intriguingly, the location
of the bands within the distal portion of the mouse Xi corre-
lates with sequences that are syntenic with human Xp22,
Xp11, Xq13, and Xq22-24 (DeBry and Seldin, 1996), sug-
gesting a conserved role for macroH2A in these regions.
 
The macroH2A band at Xq22-24 overlaps with the site 
of histone H3 lysine-4 methylation
 
In addition to a reproducible banding pattern of macroH2A
on the Xi, a distinct banding pattern of histone H3 lysine-4
methylation (DimH3K4) has been observed (Boggs et al.,
2002). Human female metaphase chromosomes stained for
macroH2A and DimH3K4 show a clear overlap of the distal
boundary of the Xq22-24 macroH2A band with DimH3K4
(Fig. 4, a, a
 
 
 
, and d). The pattern of macroH2A and
DimH3K4 at Xq22-24 is indistinguishable from that seen
Figure 3. MacroH2A displays distinct banding patterns on the 
metaphase Xi chromosome. (a) 46,XX (hTERT-RPE1) metaphase Xi 
chromosome stained with macroH2A1- or macroH2A2- (aa 124–180) 
specific pAb by indirect immunofluorescence (green, FITC), merged 
with DAPI staining (blue). The ideogram represents the metaphase 
Xi chromosome indicating the position of the X inactivation center 
(XIC) and the positions of the four main bands at Xp22, Xp11, Xq13, 
and Xq22-24. (b) Indirect immunofluorescence of macroH2A1 
banding pattern on the Xi chromosome in 46,XX (hTERT-RPE1) cells 
merged with FISH signals (red, TRITC) for ordered X chromosome 
probes, and merged with DAPI image. The white arrowheads 
indicate the location of the specific FISH probes. Overlapping 
signals are in yellow. (c) Partial metaphase spread from a 46,XX 
(hTERT-HME1) cell line stained with macroH2A1 by indirect 
immunofluorescence, merged with X-  satellite FISH signals. The 
Xa and Xi are indicated. (d) Partial metaphase spread from a female 
mouse cell line (B144) stained with macroH2A1 by indirect immu-
nofluorescence, merged with X chromosome–specific DXwas70 
FISH signals. The Xa and Xi are indicated. 
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between macroH2A and FISH with a probe of the macrosat-
ellite sequence DXZ4 (Fig. 3 b, middle). FISH analysis con-
firms that the DimH3K4 band is centered at DXZ4 on
Xq24 (Fig. 4 e).
 
Centrosomal association of macroH2A1 alters 
during the cell cycle
 
To address a possible temporal relationship between the
chromosomal and centrosomal pools of macroH2A, we ex-
 
amined the localization of macroH2A1 throughout the cell
cycle. Female cells were synchronized chemically at either
the G
 
1
 
–S boundary and released into S phase toward mito-
sis, or blocked in mitosis and released into G
 
1
 
 toward S
phase. The appearance of an MCB was most obvious during
S phase, with the loss of the MCB as cells approached mito-
sis (Fig. 5 a; Table I). In contrast, the proportion of cells
demonstrating centrosomal localization of macroH2A1 in-
creased as cells approached mitosis (Fig. 5 a; Table I). MCB
formation after release from mitosis required 
 
 
 
12 h (Fig. 5
a; Table I), whereas macroH2A1 was observed at the cen-
trosome shortly after release. The same relationship of in-
Figure 4. Overlap of the Xq22-24 macroH2A1 band with a band 
of histone H3 lysine-4 methylation centered at DXZ4. (a) Female 
metaphase chromosomes from a macroH2A1-CT–Myc-transfected 
46,XX (hTERT-RPE1) cell line counterstained with anti-DimH3K4. 
Chromosomes are stained with DAPI (blue; panel 1), and the 
distribution of macroH2A1 (green, FITC; panel 2) and DimH3K4 
(red, TRITC; panel 3) are shown. The merged distribution of 
macroH2A1 and DimH3K4 are shown in panel 4 with overlapping 
signals in orange. White arrow points to the position of the Xi. (a ) 
Enlarged image of the Xi indicated, showing the macroH2A1 and 
DimH3K4 banding patterns on the Xi. The DAPI image is merged 
with the DimH3K4 signal in the top panel to indicate the relative 
position of the DimH3K4 signal on Xq. (b) 46,XX (hTERT-RPE1) Xi 
chromosomes showing the distribution of macroH2A1-CT–Myc, 
merged with the DAPI image. The distribution is indistinguishable 
from that seen for the endogenous macroH2A1 protein (Fig. 2). 
(c) 46,XX (hTERT-RPE1) Xi chromosomes showing the distribution 
of macroH2A1-NT–Xpr, merged with the DAPI image. (d) 46,XX 
(hTERT-RPE1) Xi chromosomes showing the distribution of 
DimH3K4 merged with either the DAPI image or the distribution 
of macroH2A1-CT–Myc, with overlapping signals shown in yellow. 
(e) 46,XX (hTERT-RPE1) Xi chromosomes showing the DXZ4 locus, 
merged with the DAPI image or the DimH3K4 signal. Overlapping 
DXZ4 and DimH3K4 signals are shown in yellow.
Figure 5. Distribution of macroH2A1 in relation to the centrosome 
and XIST RNA through the somatic cell cycle. (a) Distribution of 
macroH2A1 (green, FITC) and  -tubulin (red, TRITC) in 46,XX 
(hTERT-RPE1) cells at different stages of the cell cycle as detected 
by indirect immunofluorescence. The nucleus is stained by DAPI 
(blue). Overlapping signals are shown in yellow. The positions of 
the centrosome (white arrowhead) and MCB (white arrow) are 
indicated. The stage of the cell cycle from which cells were released, 
G1–S or mitosis (M), are indicated along with the number of hours 
(h) after release. (b) Distribution of macroH2A1 and XIST RNA in 
46,XX (hTERT-RPE1) cells at different stages of the cell cycle as 
detected by indirect immunofluorescence and RNA-FISH. The 
nucleus is stained by DAPI. Overlapping signals are shown in 
yellow. The position of the centrosome (white arrowhead) and MCB 
(white arrow) are indicated. The stage of the cell cycle from which 
cells were released, G1–S or mitosis (M), are indicated along with 
the number of hours (h) after release. 
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creased centrosome association and decreased MCB fre-
quency as cells approach mitosis was observed in two other
46,XX cell lines (unpublished data), indicating that this is a
common feature of human somatic cells.
Although changes in the relative level of centroso-
mal macroH2A1 were observed as cells passed through S
phase toward mitosis, the nucleosomal concentration of
macroH2A1 did not appear to change significantly (unpub-
lished data).
 
Formation of an MCB follows, but does not mirror, 
XIST RNA accumulation
 
Disruption of XIST RNA results in the loss of MCB for-
mation (Csankovszki et al., 1999; Beletskii et al., 2001),
indicating dependence of macroH2A1 on XIST for Xi lo-
calization. To examine their temporal relationship in nor-
mal cells, we monitored MCB formation in relation to
XIST RNA during the somatic cell cycle. XIST RNA
paints the Xi during interphase (Clemson et al., 1996), but
unlike mouse Xist (Duthie et al., 1999), human XIST
RNA does not remain associated with the Xi during mito-
sis (Clemson et al., 1996). An XIST RNA domain was ob-
served in cells throughout S phase and G
 
2
 
 and only dissoci-
ated from the Xi as cells entered mitosis (Fig. 5 b; Table
II), consistent with earlier findings (Clemson et al., 1996).
XIST RNA was expressed and formed an XIST RNA do-
main shortly after release from mitosis (Fig. 5 b; Table II).
 
In contrast, MCBs dissociated from the Xi chromatin as
cells approached mitosis, significantly earlier than XIST
RNA, and did not rapidly reform with the XIST RNA ter-
ritory shortly after mitosis (Fig. 5 b; Table II). With the
exception of a very small number of cells, an MCB was
present only in cells with an XIST RNA domain. This in-
dicates that although the association of XIST RNA with
the Xi is a prerequisite for an MCB, the formation of an
MCB is strongly influenced by the cell cycle.
 
MCB formation is influenced by the cell cycle and is 
most prominent during S phase
 
To relate MCB formation directly with DNA replication
during S phase, cells were synchronized and pulsed with
BrdU for 1 h after different release times to detect exit
and entry into S phase. Unlabeled cells after release from
mitosis had not yet entered S phase (Fig. 6 a), whereas un-
labeled cells after release from G
 
1
 
–S had exited S phase
and entered G
 
2
 
. Chromatin of the Xi is late replicating in
S phase (Gilbert et al., 1962; Morishma et al., 1962), and
therefore the MCB is only labeled in late S phase cells
(Fig. 6 a). This, in combination with time of release, al-
lows accurate determination of early, middle, and late S
phase. Cells released from mitosis into G
 
1
 
 took 
 
 
 
15 h to
enter S phase as detected by BrdU incorporation. Only
23% of cells in G
 
1
 
 had an MCB (Fig. 6 b). In contrast,
MCBs were observed in 72% of cells in early S phase.
 
Table I. 
 
Association of macroH2A1 with MCBs and 
 
 
 
-tubulin in 46,XX (hTERT-RPE1) cells at different stages of the cell cycle
Cell cycle stage Cells with MCB Cells with centrosome association Cells with no MCB or centrosome association
 
Early S phase 95 
 
 
 
 1.4 54 
 
 
 
 2.8 2 
 
 
 
 
 
 
 
0.01
Mid to late S phase 74 
 
 
 
 2.8 84 
 
 
 
 2.8 2 
 
 
 
 
 
 
 
0.01
Late S phase 52 
 
 
 
 2.8 93 
 
 
 
 1.4 3 
 
 
 
 1.4
G
 
2
 
22 
 
 
 
 2.8 93 
 
 
 
 1.4 4 
 
 
 
 2.8
Mitosis 0 
 
 
 
 
 
 
 
0.01 5 
 
 
 
 4.2 95 
 
 
 
 4.2
Early G
 
1
 
1 
 
 
 
 1.4 55 
 
 
 
 4.2 45 
 
 
 
 4.2
Mid G
 
1
 
3 
 
 
 
 1.4 100 
 
 
 
 
 
 
 
0.01 0 
 
 
 
 
 
 
 
0.01
Late G
 
1
 
 to early S 39 
 
 
 
 4.2 98 
 
 
 
 2.8 1 
 
 
 
 1.4
Cells were synchronized at the G
 
1
 
–S boundary or in mitosis and released for 0–12 h before detection of macroH2A1 and 
 
 
 
-tubulin by indirect
immunofluorescence. Numbers of cells are given as a percentage with standard deviations (
 
n
 
 = 100). Early S phase, cells at the G
 
1
 
–S boundary; mid to late
S phase, G
 
1
 
–S 
 
 
 
 4 h; late S phase, G
 
1
 
–S 
 
 
 
 8 h; G
 
2
 
, G
 
1
 
–S + 12 h; mitosis, release from nocodazole for 1 h; early G
 
1
 
, mitosis 
 
 
 
 4 h; mid G
 
1
 
, mitosis 
 
 
 
 8 h;
late G
 
1
 
 to early S, mitosis 
 
 
 
 12 h.
Table II. 
 
Frequency of macroH2A1 MCBs and XIST RNA association with the Xi in 46,XX (hTERT-RPE1) cells at different stages of the
cell cycle
Cell cycle stage Cells with MCB association with Xi Cells XIST RNA association with Xi
Cells with no MCB XIST RNA 
association with Xi
 
Early S phase 81 
 
 
 
 9.9 99 
 
 
 
 1.4 1 
 
 
 
 1.4
Mid to late S phase 64 
 
 
 
 5.6 98 
 
 
 
 
 
 
 
0.01 1 
 
 
 
 1.4
Late S phase 48 
 
 
 
 2.8 99 
 
 
 
 1.4 0 
 
 
 
 
 
 
 
0.01
G
 
2
 
19 
 
 
 
 4.2 67 
 
 
 
 4.2 33 
 
 
 
 4.2
Mitosis 0 
 
 
 
 
 
 
 
0.01 1 
 
 
 
 1.4 99 
 
 
 
 1.4
Early G
 
1
 
0 
 
 
 
 
 
 
 
0.01 68 
 
 
 
 2.8 32 
 
 
 
 2.8
Mid G
 
1
 
5 
 
 
 
 1.4 99   1.4 1   1.4
Late G1 to early S 33   4.2 98    0.01 1   1.4
Cells were synchronized at the G1–S boundary or in mitosis and released for 0–12 h before detection of macroH2A1 and XIST RNA by indirect
immunofluorescence and RNA FISH. Numbers of cells are given as a percentage with standard deviations (n = 100). Early S phase, cells at the G1–S boundary;
mid to late S phase, G1–S   4 h; late S phase, G1–S   8 h; G2, G1–S   12 h; mitosis, release from nocodazole for 1 h; early G1, mitosis   4 h; mid G1,
mitosis   8 h; late G1 to early S, mitosis   12 h.1118 The Journal of Cell Biology | Volume 157, Number 7, 2002
MCB frequency peaked at 93% in cells 5 h after release
from G1–S, before dropping sharply late in S phase and in
G2. As shown in Fig. 6 b, these data clearly indicate that
the appearance of an MCB is most prominent during S
phase, in agreement with timing of MCB formation after
mitosis and loss of MCBs as cells pass through S phase
(Fig. 5; Tables I and II).
Inhibition of the 20S proteasome results in the 
accumulation of macroH2A1 at the centrosome
The proteasome is a large multisubunit proteolytic complex
that is the major site of protein degradation (Bochtler et al.,
1999). Components of the proteasome have been identified
in purified centrosome fractions (Wigley et al., 1999) that
are capable of degrading ubiquitinated substrates (Fabunmi
et al., 2000). To evaluate the potential association of
macroH2A1 with the proteasome, cells were synchronized at
the G1–S boundary and in mitosis before releasing in the
presence of lactacystin, an irreversible proteasome inhibi-
tor (Fenteany et al., 1995). Centrosomal accumulation of
macroH2A1 significantly increased after incubation for 12 h
in lactacystin and colocalized with an enlarged ubiquitin do-
main (Fig. 7), whereas an accumulation of macroH2A2 was
not detected (unpublished data). The dramatic accumulation
of macroH2A1 at the centrosome after inhibition of the pro-
teasome is consistent with the inability to degrade the pro-
tein, suggesting that macroH2A1 may be targeted to the cen-
trosome for degradation. The appearance of an enlarged
macroH2A1 domain at the centrosome occurs between 8–12 h
after release from G1–S or mitosis. More cells acquired an
enlarged centrosomal macroH2A1 domain when released
from G1–S (91% of cells) than from mitosis (71%), perhaps
indicating that more macroH2A1 is targeted for degradation
Figure 6. Distribution of macroH2A1 in synchronized 46,XX 
(hTERT-RPE1) cells in different stages of the somatic cell cycle. 
(a) The late G1 cell was released from mitosis for 14 h and pulsed 
with BrdU for 1 h before detection of macroH2A1 (green, FITC) and 
BrdU (red, TRITC). The nucleus is stained with DAPI (Blue). The cell 
has not yet entered S phase, as determined by the lack of an anti-
BrdU signal. The early S phase cell was released from mitosis for 16 h 
and pulsed with BrdU for 1 h before detection of macroH2A and 
BrdU. The nucleus is stained with DAPI and merged with the anti-
BrdU signal. The position of the MCB is indicated by the white 
arrowhead and, as indicated by the merged macroH2A1 and BrdU 
signals (yellow), has not yet undergone DNA replication. The late S 
phase cell was released from G1–S for 9 h and pulsed with BrdU for 
1 h before detection of macroH2A1 and BrdU. The nucleus is 
stained with DAPI and merged with the anti-BrdU signal. The
position of the MCB is indicated by the white arrowhead and, as 
indicated by the merged macroH2A1 and BrdU signals (yellow), 
is currently undergoing DNA replication. (b) Graph showing the 
frequency of MCB observation at different stages of the somatic cell 
cycle. Synchronized 46,XX cells (hTERT-RPE1) released for different 
time periods from the G1–S boundary or mitosis and pulsed for 1 h 
with BrdU. Cells were scored for the presence of an MCB at 
different cell cycle stages.
Figure 7. Colocalization of macroH2A1 with ubiquitin and
accumulation at the centrosomal proteasome over time with 
inhibition of the 20S proteasome. 46,XX (hTERT-RPE1) cells were 
synchronized at G1–S or mitosis (M) and directly processed (0 h/1 h) 
or released for 12 h (12 h) in the presence of 10  M lactacystin. The 
distribution of macroH2A1 (green, FITC) (mH2A) and ubiquitin 
(red, TRITC) (Ub) are shown by indirect immunofluorescence. The 
nucleus is stained with DAPI (blue). The white arrowheads indicate 
the position of the centrosome proteasome marked by ubiquitin, 
and the small white arrows indicate the position of MCBs. Overlapping 
macroH2A1 and ubiquitin (yellow) show colocalization and 
accumulation 12 h after G1–S and mitosis in the presence of the 
proteasome inhibitor lactacystin.Distribution of macroH2A during the cell cycle | Chadwick and Willard 1119
as cells pass through S phase and G2 than in G1. This may re-
flect the remodeling of chromatin in preparation for mitosis
and the need to remove macroH2A1 released in this process.
Centrosome association and accumulation is a feature 
of some, but not all, chromatin proteins
To determine how specific macroH2A1 association with the
centrosome is, we looked at a number of other chromatin pro-
teins for centrosome association (Fig. 8 a). Of 29 chromatin
proteins tested, 8 demonstrated a clear overlap with  -tubulin
at mitosis (Fig. 8 a) and interphase (unpublished data). To ad-
dress the possibility that, like macroH2A1, the centrosomal
association of these chromatin proteins represents a degrada-
tion pathway, cells were treated with lactacystin and moni-
tored for the accumulation of each chromatin protein at the
centrosome (Fig. 8 b). Indeed, several of the chromatin pro-
teins demonstrated a dramatic increase in size at the cen-
trosome and colocalization with ubiquitin (Fig. 8 b). In
contrast, DNA–methyltransferase 3a (DNMT3a) remained
absent from the centrosome, but consistently accumulated at
two nuclear foci (Fig. 8 b), suggesting that this protein is di-
rected to an alternative proteasome center. Taken together,
these data imply that targeting of chromatin proteins to the
centrosome is a common mechanism of protein degradation.
Discussion
MacroH2A1 associates with the centrosome in a 
manner characteristic of a degradation pathway
The association of macroH2A at the centrosome is not re-
stricted to undifferentiated mouse ES cells (Rasmussen et al.,
2000), but is a common feature of male and female mouse
(Mermoud et al., 2001) and human somatic cells (Fig. 1 a).
Centrosomal macroH2A is composed of both macroH2A1
and macroH2A2 (Fig. 1 b and Fig. 2 a), indicating that both
proteins are spatially indistinguishable at the centrosome.
Recently, a link has been made between protein degrada-
tion pathways and the centrosome. Treatment of cells with
lactacystin, a potent inhibitor of the 20S proteasome (Fente-
any et al., 1995), results in the dramatic formation of peri-
nuclear protein aggregates (Wojcik et al., 1996). In the
absence of lactacystin, a variety of mutant misfolded or over-
expressed proteins also accumulate in perinuclear aggregates
(referred to as aggresomes) that are centered at the cen-
trosome (Johnston et al., 1998; Garcia-Mata et al., 1999).
Once aggresomes form, they appear to be highly resistant to
proteolysis (Kopito and Sitia, 2000) and are thought to be a
major contributor to the pathology of disease (Kopito,
2000). Most compelling is the detection and purification of
Figure 8. Colocalization of a number 
of heterochromatin proteins with 
centrosomes at mitosis, and accumulation 
at the centrosome proteasome in the 
presence of lactacystin. (a) Indirect 
immunofluorescence of heterochromatin 
proteins (green, FITC) with  -tubulin 
(red, TRITC) in 46,XX (hTERT-RPE1) at 
mitosis. Chromosomes are stained with 
DAPI (blue). Overlapping heterochromatin 
protein signals and  -tubulin signals in 
merged images are indicated in yellow. 
The different heterochromatin proteins 
are indicated to the left of each group 
of panels. (b) Extensive incubation of 
46,XX (hTERT-RPE1) cells with lactacystin 
results in the accumulation of some, but 
not all, heterochromatin proteins at the 
centrosome proteasome. Cells were 
treated with 10  M lactacystin for 14 h 
before processing. Ubiquitin and pro-
teins indicated were detected by indirect 
immunofluorescence. Clear overlap-
ping signals with ubiquitin can be seen 
(yellow). White arrowheads indicate the 
accumulation of Dnmt3a with two 
nuclear territories and not with the 
centrosome proteasome. Gene names 
are defined in the Materials and methods.1120 The Journal of Cell Biology | Volume 157, Number 7, 2002
active components of the proteasome at the centrosome
(Wigley et al., 1999; Fabunmi et al., 2000). The accumula-
tion of macroH2A1 at the centrosome in the presence of lac-
tacystin (Fig. 7) suggests that macroH2A1 is targeted to the
centrosome–proteasome as part of a degradation pathway.
In contrast, despite the association of macroH2A2 with the
centrosome (Fig. 1 b and Fig. 2 a), an accumulation was not
detected in the presence of lactacystin (unpublished data).
One explanation for this could be that macroH2A2 is tar-
geted primarily to a nuclear proteasome center for degrada-
tion with centrosomal proteasome–mediated degradation
being secondary. Alternatively, lactacystin may prevent the
export of macroH2A2 but not macroH2A1 from the nu-
cleus. Ultimately, this may reflect a difference in the biology
of the two macroH2A proteins, or a sensitivity issue regard-
ing the antisera. Notably, poly-ADP ribose polymerase, an
activator of the 20S proteasome to degrade histones dam-
aged by oxidation in the nucleus (Ullrich et al., 1999), is also
located at the centrosome (Kanai et al., 2000) and may acti-
vate the centrosomal proteasome in a similar fashion.
Although a common feature of proteins targeted for deg-
radation is the addition of polyubiquitin chains (Pickart,
2001), exhaustive immunoprecipitation experiments using
antisera raised to ubiquitin failed to immunoprecipi-
tate polyubiquitinated forms of macroH2A (unpublished
data). Close examination of the extensive overlap in the
macroH2A1 and ubiquitin signals in the aggresome indi-
cates a hole in the macroH2A1 signal at the center of the ag-
gresome (Fig. 7). This is also true of the macroH2A1 signal
before lactacystin treatment (Fig. 7), placing macroH2A1 in
the pericentriolar material, as confirmed by the absence of
macroH2A1 signal at the centrioles marked by  -tubulin
(Figs. 1 and 5). Although ubiquitination is a common signal
for targeting proteins to the proteasome (Bochtler et al.,
1999), other proteins are targeted to the proteasome for deg-
radation in the absence of detectable ubiquitination (Garcia-
Mata et al., 1999). Therefore macroH2A1 may be targeted
to the proteasome in a ubiquitin-independent fashion or else
macroH2A1 is targeted through a physical association with
other ubiquitinated proteins. Alternatively, the mono-ubiq-
uitinated form of macroH2A, which is readily detectable
(unpublished data), may be sufficient for targeting for degra-
dation as previously demonstrated for histone H3 (Haas et
al., 1990).
In addition to macroH2A1, a number of other chromatin
proteins associate with the centrosome (Hsu and White,
1998; Barthelmes et al., 2000; Xue et al., 2000) (Fig. 8 a).
Like macroH2A1, treatment of cells with lactacystin results
in the association of some, but not all, chromatin proteins
with aggresomes (Fig. 8 b). This indicates that targeting of
chromatin proteins to the centrosomal proteasome is a fairly
common mechanism. The fact that DNMT3a not associ-
ated with the centrosome (Fig. 8 a) is consistently targeted
to two nuclear proteolysis centers (Fig. 8 b), and not to the
centrosomal proteasome, indicates that different chromatin
proteins are targeted to different proteolysis centers. In addi-
tion, export from the nucleus is not a requisite for chromatin
protein degradation, and the site of degradation for each
protein is specific. Why a selection of nuclear proteins is tar-
geted to the centrosomal proteasome, instead of the proteol-
ysis centers in the nucleus, is unclear. Given its association
with gene silencing (Perche et al., 2000), it is possible that
nonnucleosomal macroH2A1 may retain the ability to inter-
act with partners in the nucleus and thus needs to be rapidly
exported to prevent macroH2A1 from having detrimental
effects on the cell by sequestering chromatin complexes. Al-
ternatively, factors involved in the remodeling of chromatin,
resulting in the potential release of macroH2A1, may them-
selves be targeted to the centrosomal proteasome, taking
macroH2A1 with them.
Centrosomal concentrations of macroH2A1 alter in a cell
cycle–dependent fashion. As cells proceed through S phase
and G2 toward mitosis, the concentration of macroH2A1 at
the centrosome increases to a level detectable by immunoflu-
orescence (Fig. 5 a; Table I). The same trend is observed as
cells proceed from mitosis through G1 toward S phase (Fig.
5 a; Table I). The accumulation of macroH2A1 at the cen-
trosome in the presence of lactacystin is most prominent in
cells as they pass through S phase toward mitosis. This is
consistent with the need to target more macroH2A1 for deg-
radation, as it is during this period that the MCB disappears,
suggesting that excess quantities of macroH2A1 are required
to be removed.
The association of macroH2A1 with the Xi chromatin 
is most prominent at S phase
A prerequisite for the formation of an MCB is the associa-
tion of XIST RNA with the Xi (Csankovszki et al., 1999;
Beletskii et al., 2001). Whereas XIST RNA coats the Xi
through early G1 to late G2, the stable presence of XIST does
not immediately direct macroH2A1 to the Xi to form
an MCB (Fig. 5 b; Table II). Instead, the formation of an
MCB is most common in early and middle S phase (Fig. 6
b). MacroH2A1 is unlikely to be marking chromatin for
late replication, as not all sites of late replication overlap
with macroH2A1 staining (Fig. 6 a), and the banding of
macroH2A at metaphase (Figs. 3 and 4) does not corre-
spond to regions of the Xi known to replicate latest in S
phase (Willard, 1977).
The cell cycle–influenced appearance of an MCB suggests
that macroH2A1 (and perhaps macroH2A2) may be substi-
tuting the H2A position in Xi nucleosomes at and around S
phase. Although the nucleosome inner core of histones H3
and H4 is stable at interphase, H2B is more dynamic and
can readily be substituted (Kimura and Cook, 2001). H2A
and H2B are deposited onto chromatin as a heterodimer
(Ridgway and Almouzni, 2000). Therefore it is conceivable
that H2A variants, like H2B, can also dynamically exchange
the H2A position, conferring alternative states to local chro-
matin. Preparations of nucleosomes from cells blocked at the
beginning of S phase or in mitosis have comparable levels of
macroH2A1 (unpublished data), despite the significant de-
crease in macroH2A at the Xi as the MCB disappears (Fig.
5). Put into a genomic perspective, fluctuations in the local
concentrations of macroH2A1 at the Xi visualized as an
MCB in females may be masked by the total concentrations
of nucleosomal macroH2A1 in a cell. This may indicate that
macroH2A1 at the MCB represents only a small fraction of
the total concentration of macroH2A1, with the remainder
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Indistinguishable concentrations of macroH2A in male and
female nucleosome fractions and total cell extracts support
this (unpublished data). More speculatively, it is conceivable
that macroH2A1 at the MCB is not all nucleosomal, but
functioning with other components of the dosage compen-
sation complex at the Xi outside of the nucleosome context.
Resolving this issue will require a detailed analysis of nucleo-
some levels of macroH2A at the Xi by chromatin immuno-
precipitation analysis at different stages of the cell cycle.
One possible model to explain the functional significance
of the MCB during S phase is that higher local concentra-
tions of macroH2A may be one of many redundant mecha-
nisms to promote the loading of the dosage compensation
complex onto the daughter X and mark it as the Xi as it is
synthesized.
MacroH2A is enriched at specific bands 
on the metaphase Xi overlapping a site 
of histone H3 methylation
Although the MCB is not evident before the onset of mitosis
(Fig. 5; Tables I and II), macroH2A1 does remain associated
with both the human and mouse Xi during mitosis as distinct
bands (Figs. 3 and 4). Intriguingly, these bands appear to
mimic the banding seen with Xist RNA on the mouse Xi dur-
ing mitosis (Duthie et al., 1999), suggesting that macroH2A
may be functioning to anchor Xist RNA in cis with the Xi.
However, in humans, XIST RNA does not remain associated
with the Xi during mitosis (Clemson et al., 1996). Bands en-
riched for macroH2A may function as reentry sites for XIST
RNA and the dosage compensation complex, assisting in the
rapid spread along the Xi in a manner analogous to reentry
sites of the Drosophila dosage compensation complex (Meller
et al., 2000). The band of macroH2A at the site of the XIST
locus (Fig. 3 b) is perhaps analogous to reentry of the Dro-
sophila dosage compensation complex at the site of the roX1
and roX2 loci (Kelley et al., 1999). Why macroH2A remains
associated specifically with these regions of the chromosome is
intriguing. With the exception of the proximity of macroH2A
to the satellite repeat DXZ4 at Xq22-24 (Giacalone et al.,
1992), there are no obvious shared features, such as gene den-
sities or frequency of repeated elements at the chromatin of
the other identified regions.
Most intriguing is the clear overlap of the macroH2A
band at Xq22-24 with a band of histone H3 lysine-4 meth-
ylation (Fig. 4, a, a , and d). The band of DimH3K4 is cen-
tered at DXZ4 (Fig. 3 e) and marks the distal edge of the
macroH2A band. This demonstrates the association of a his-
tone modification, thought primarily to associate with eu-
chromatin and regions of transcriptional activation (Kou-
zarides, 2002, and references therein), with a macrosatellite
repeat (Giacalone et al., 1992). Potentially, DXZ4 may act
as a boundary element, delimiting the spread of macroH2A,
strengthened by the H3 lysine-4 methylation. Identification
of genomic sequences and chromatin modifications at the
boundary of each of the macroH2A bands will provide in-
valuable insight into the functional significance and influ-
ence of the histone code used by the Xi.
The MCB observed in interphase and the banding of
macroH2A seen at metaphase (Figs. 3 and 4) might provide
similar or separate functions. Although disruption of XIST
results in the loss of detectable MCB formation (Csan-
kovszki et al., 1999; Beletskii et al., 2001), this may not ef-
fect macroH2A at the chromosome bands. Targeting of
macroH2A1 and macroH2A2 in human and mouse ES
cells, along with carefully directed chromatin immunopre-
cipitation experiments, will further our understanding of the
functional significance of macroH2A in X inactivation.
Materials and methods
Cell culture and chemical treatment
Cell lines used include T-3352, a 46,XX human primary fibroblast strain
(provided by Stuart Schwartz, Case Western Reserve University); hTERT-
RPE1, a 46,XX telomerase-immortalized cell line derived from a human
retinal pigment epithelial cell line RPE-340 (catalog no. C4000–1; CLON-
TECH Laboratories, Inc.); hTERT-BJ1, a 46,XY telomerase-immortalized
cell line derived from a human primary foreskin fibroblast cell line (catalog
no. C4001–1; CLONTECH Laboratories, Inc.); hTERT-HME1, a 46,XX tel-
omerase-immortalized cell line derived from a human mammary epithe-
lial cell line (catalog no. C4002–1; CLONTECH Laboratories, Inc.); and
HEK-293, a female fetal kidney tumor cell line. B144 is a female mouse
primary fibroblast cell line (provided by Laura Carrel, Case Western Re-
serve University). Cells were maintained as described previously (Chad-
wick and Willard, 2001a).
To establish stably transfected cell lines, hTERT-RPE1 or HEK-293 cells
were transfected with 5  g of carboxy-terminal Myc-tagged macroH2A1
(macroH2A1-CT–Myc), amino-terminal Xpress-tagged macroH2A1
(macroH2A1-NT–Xpr), or a carboxy-terminal Myc-tagged macroH2A2
(macroH2A2-CT–Myc) expression using Superfect according to the manu-
facturer’s recommendations (QIAGEN) and grown for 48 h before selec-
tion with either 1.4 mg/ml (hTERT-RPE1) or 0.4 mg/ml (HEK-293) neomy-
cin (GIBCO BRL).
Cell synchronization and BrdU (Sigma-Aldrich) incorporation were per-
formed as previously described (Spector et al., 1998).
Inhibition of the 20S proteasome was achieved by washing cell lines
twice with PBS and applying complete media containing 10  M lactacys-
tin (Calbiochem) (Fenteany et al., 1995) for the time periods indicated at
37 C in a 5% CO2 atmosphere.
Antibodies
Rabbit pAbs against the nonhistone tail region of macroH2A1 have been
previously described (Chadwick and Willard, 2001a). Two glutathione-
S-transferase (GST)–macroH2A2 fusion proteins covering amino acids 124–
180 (aa 124–180) and amino acids 124–372 (aa 124–372) were used to
raise independent rabbit pAbs to macroH2A2 (Covance Inc.). MacroH2A1
and macroH2A2 (124–180) pAbs were affinity purified. MacroH2A1 and
both macroH2A2 antisera were blocked against each other using standard
techniques (Harlow and Lane, 1989) to generate antisera specific to each
form of the protein. Specificity was confirmed by Western analysis (unpub-
lished data). Monoclonal anti– -tubulin (clone gtu-88) was obtained from
Sigma-Aldrich. Mouse mAb anti-BrdU (clone BMC 9318) was obtained
from Roche Diagnostics Corp. Mouse mAb antiubiquitin (clone 6C1) was
obtained from Oncogene Research Products. Polyclonal antisera raised
to histone deacetylases 1 (HDAC1, sc-7872) and 3 (HDAC3, sc-8138),
DNA–methyltransferases 1 (Dnmt1, sc-10222), 2 (Dnmt2, sc-10227), 3a
(Dnmt3a, sc-10231), and 3b (Dnmt3b, sc-10235), histone acetyltransfer-
ase p300/CBP-associated factor (PCAF, sc-8999), and methyl-DNA bind-
ing proteins 1 (MBD1, sc-9395) and 3 (MBD3, sc-9402) were obtained
from Santa Cruz Biotechnology Inc. Antihistone H3 dimethyl lysine-4
(DimH3K4) was obtained from Upstate Biotechnology. Anti–Mi-2 was a
gift from Paul Wade (Emory University, Atlanta, GA). Mouse mAbs anti-
Myc and anti-Xpress were obtained from Invitrogen.
Immunofluorescence and FISH
Immunofluorescence and FISH was performed essentially as previously
described (Chadwick and Willard, 2001b). Slides were denatured at 85 C
before FISH, as opposed to 72 C, to overcome extensive sample fixation. A
digoxygenin-labeled DXZ4 probe was obtained from Oncor Inc. Human X
chromosome TRITC-labeled probes were generated using a nick transla-
tion kit (Vysis Inc). A mouse X chromosome–specific probe, DXwas70,
was used to detect the mouse X chromosome. Human cosmid clones
ICRFc100H0130 (XIC) and ICRFc100G11100 (CIC8) were obtained from
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RNA FISH was achieved by first immunostaining followed by RNA-FISH
essentially as previously described (Clemson et al., 1996).
Metaphase chromosomes were prepared as described previously (Chad-
wick and Willard, 2001b). Single-copy probes were blocked for repetitive
sequences for 1 h at 37 C in the presence of 0.3 mg/ml human Cot-1 DNA
before hybridization. Immunostaining of BrdU-pulsed cells was achieved
by first fixing and staining for macroH2A as described previously (Chad-
wick and Willard, 2001a), before proceeding as described by Spector et al.
(1998).
Images were collected with a Vysis imaging system equipped with a
cooled CCD camera (Photometrics) controlled via the Quips M-FISH
TM
software (Vysis Inc).
Relative cell cycle stages were determined by cell cycle arrest and re-
lease in conjunction with BrdU pulse labeling. Presence or absence of
BrdU incorporation was monitored relative to the number of hours after re-
lease and translated directly to subsequent surveys.
Preparation of centrosomes and nucleosomes
Centrosomes were isolated essentially as previously described (Bornens
and Moudjou, 1999). Nucleosome oligomers were isolated as described
previously (Chadwick and Willard, 2001b). Protein samples were sepa-
rated by SDS-PAGE and transferred to a polyvinylidene diflouride mem-
brane using standard techniques (Harlow and Lane, 1989).
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